LFWD Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-18.330.0% YoY
Profit margin-123.7%HEALTHCARE
Market cap$19.4MMicro cap

Wall Street coverage

$20.00median target· current $50.28 (-60.2%)2 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
PEG ratio
P/B
3.04
P/S (TTM)
0.94
EV/EBITDA
1.03

Profitability & growth

ROE (TTM)
-209.1%
Operating margin
-123.4%
Revenue growth YoY
-22.1%
Dividend yield
Beta
0.37
Last earnings
May 15, 2026 · Estimate $-0.34 · Reported $-6.70
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About ReWalk Robotics Ltd

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company is headquartered in Yokneam Illit, Israel.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
3 HATNUFA ST., YOKNEAM ILLIT, ISRAEL
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$19.4M
Shares outstanding$2.8M
52W high$12.60
52W low$4.14

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer